Monday Lecture Series
Vaccines that Target Dendritic Cells
Sarah Schlesinger M.D.
Senior Attending Physician and Associate Professor of Clinical Investigation
Cellular Physiology and Immunology
March 7, 2011
4:00 p.m.-5:00 p.m. Caspary Auditorium
Dhodapkar MV; Sznol M; Wang D, et al. 2010. Early development of CDX-1401, a novel vaccine targeting NY-ESO-1 to the dendritic cel receptor DEC-205. Journal of Immunotherapy. 33(8):895-896 Request Article from Markus Library.
Wanialla CN; Faul EJ; Gomme EA, et al. 2010. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity. Vaccine. 29(1):130-140
Fiorentini S; Giagulli C; Caccuri F, et al. 2010. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS. Pharmacology & Therapeutics. 128(3):433-444 Request Article from Markus Library.
De Groot A; Buhlmann J; Weber C, et al. 2010. De-Tolerization of anti-DEC-205 for HIV vaccine delivery. (abstract only) AIDS Research and Human Retroviruses. 26(10):A135-A136
Ahlers, JD; and IM Belyakov. 2009. Strategies for optimizing targeting and delivery of mucosal HIV vaccines. European Journal of Immunology. 39(10):2657-2669
Kloverpris HN; Karlsson I; Thorn M, et al. 2009. Immune hierarchy among HIV-1 CD8+T cell epitopes delivered by dendritic cells depends on MHC-I binding irrespective of mode of loading and immunization of HLA-A*0201 mice. APMIS 117(11):8489-855
Demberg T; and M. Robert-Guroff. 2009. Mucosal immunity and protection against HIV-SIV infection: strategies and challenges for vaccine design. International Reviews of Immunology. 28(1-2):20-28 Please request from Markus Library.
Gruber A; Chalmers AS; Rasmussem RA, et al. 2007. Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile. Viral Immunology. 20(1):160-169.